Stephan Seitz Selected Research

RC 121

8/2010	Targeted cytotoxic somatostatin analog AN-162 inhibits growth of human colon carcinomas and increases sensitivity of doxorubicin resistant murine leukemia cells.
9/2009	Inhibition of human non-small cell lung cancers with a targeted cytotoxic somatostatin analog, AN-162.
8/2009	Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Seitz Research Topics

Disease

15	Neoplasms (Cancer) 08/2018 - 05/2007
6	Breast Neoplasms (Breast Cancer) 05/2022 - 11/2008
6	Triple Negative Breast Neoplasms 01/2018 - 07/2009
2	Colonic Neoplasms (Colon Cancer) 11/2012 - 07/2012
2	Carcinoma (Carcinomatosis) 08/2010 - 04/2008
1	Mesothelioma 01/2021
1	Endometrial Neoplasms (Endometrial Cancer) 08/2018
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 08/2010
1	Leukemia 08/2010
1	Lung Neoplasms (Lung Cancer) 09/2009
1	Liver Neoplasms (Liver Cancer) 04/2008
1	Hepatocellular Carcinoma (Hepatoma) 04/2008
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 05/2007

Drug/Important Bio-Agent (IBA)

5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 02/2013 - 04/2008
5	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 11/2012 - 11/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2014 - 08/2009
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 11/2014 - 04/2008
4	Estrogens (Estrogen)FDA Link 04/2012 - 11/2008
3	Somatostatin Receptors (Somatostatin Receptor)IBA 02/2013 - 08/2009
3	PhAcTyr(1)- Arg(2)- P(H)e(4- CL)(6)- Ala(8)- Tyr(Me)(10)- His(11)- Abu(15)- His(20)- Nle(27)- Arg(28)- HLCr(29)- GHRH(1-29)NH2IBA 11/2012 - 11/2008
3	RC 121IBA 08/2010 - 08/2009
3	Messenger RNA (mRNA)IBA 10/2009 - 07/2009
2	Fluorouracil (Carac)FDA LinkGeneric 11/2012 - 07/2012
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2012 - 07/2012
2	Cytotoxins (Cytolysins)IBA 11/2012 - 07/2012
2	BombesinIBA 07/2012 - 04/2008
2	somatotropin releasing hormone receptorIBA 01/2012 - 07/2009
2	Peptides (Polypeptides)IBA 08/2009 - 04/2008
1	brigatinibIBA 01/2021
1	CrizotinibIBA 01/2021
1	NitrogenIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	N- (2- diethylaminoethyl)- N- (2- hydroxy- 2- phenylethyl)- 2,5- dichloroanilineIBA 02/2013
1	Cisplatin (Platino)FDA LinkGeneric 11/2012
1	Hca(6)-Leu(13)-psi(CH2N)-Tac(14)- bombesin(6-14)IBA 07/2012
1	Gastrin-Releasing PeptideIBA 07/2012
1	gastrin releasing peptide (14-27)IBA 07/2012
1	Epidermal Growth Factor (EGF)IBA 04/2012
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 04/2012
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	TOR Serine-Threonine KinasesIBA 01/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2012
1	AndrogensIBA 01/2012
1	cetrorelix (Cetrotide)FDA Link 10/2009
1	glutaric acidIBA 08/2009
1	Progesterone FDA LinkGeneric 07/2009
1	Estrogen ReceptorsIBA 11/2008
1	sodium-iodide symporter (sodium iodide symporter)IBA 05/2007
1	Sodium Pertechnetate Tc 99m (Pertechnetate)FDA Link 05/2007
1	Iodine-131IBA 05/2007
1	Radioisotopes (Radionuclides)IBA 05/2007
1	Therapeutic UsesIBA 05/2007

Therapy/Procedure

7	Therapeutics 01/2021 - 05/2007
2	Lymph Node Excision (Lymph Node Dissection) 08/2018 - 05/2018
2	Drug Therapy (Chemotherapy) 08/2009 - 07/2009
1	Mastectomy (Mammectomy) 05/2022
1	Mammaplasty (Breast Reconstruction) 01/2022
1	Radiotherapy 08/2018
1	Brachytherapy 08/2018
1	Chemoradiotherapy 05/2018
1	Immunotherapy 01/2018
1	Castration 01/2012
1	Injections 10/2009